Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

RxFiber's RxFibron HT, High Tenacity Biomaterial for Lower Profile Medical Devices Awarded the Golden Mousetrap Award at MD&M West
  • USA - English


News provided by

RXFIBER, LLC

Feb 18, 2014, 08:30 ET

Share this article

Share toX

Share this article

Share toX

RxFibron HT RxFiber
RxFibron HT RxFiber

"Engineers will have the ability to develop lower-profile devices while maintaining the strength and integrity of the device," says Robert Torgerson, Founder and President of RxFiber.

Post this

Windsor, CA (PRWEB) February 18, 2014 -- RxFiber, LLC today announced that its high tenacity, next generation biomaterial for implantable medical devices, http://www.rxfiber.com/fibers/rxfibron-ht©;.aspx [RxFibron HT __title__ RxFiber HT Biomaterial for medical devices], has been selected as a Golden Mousetrap Winner in the Materials and Assembly category. Through the Golden Mousetrap Awards program, UBM Canon celebrates the success of the people, companies, and technologies that are driving progress in today’s U.S. design and manufacturing industries. Specifically, they are celebrating the return and renaissance of manufacturing in North America by honoring those companies and people who are making it possible During a live ceremony, RxFiber’s President, Robert Torgerson, was presented the Golden Mousetrap Award on February 11, 2014.

"RxFiber is honored to receive the Golden Mousetrap Award for our RxFibron HT fiber. We are so excited and thankful to be recognized by UBM Cannon and Design News for our efforts. Thank you Design News for this prestigious Golden Mousetrap Award," said Mr. Torgerson, President of RxFiber.

RxFiber, the first manufacturer dedicated solely to engineering medical-grade fibers for the medical device industry, has developed and commercially released its latest award winning product, RxFibron HT, a high-tenacity PET (Polyester) biomaterial for medical device applications. As an innovative alternative to UHMWPE and regular Polyester, RxFibron HT features several advantages over current market fibers including durability, high strength, thermal melt properties for ease of manufacturing, and custom size variations suitable for creating lower-profile devices. The revolutionary RxFibron HT is the first commercially available high-tenacity, medical-grade PET biomaterial that can be used to create next-generation implantable devices, such as sutures, composites, and more for applications such as endovascular, vascular, and orthopedics.

"Engineers will have the ability to develop lower-profile devices while maintaining the strength and integrity of the device," says Robert Torgerson, Founder and President of RxFiber and leading expert in biomaterial medical device design. "RxFibron HT meets the criteria of having substantial strength, biocompatibility, lower profile (smaller denier yarn), and custom size fibers. High-tenacity PET fibers are a substantial upgrade from regular Polyester and will yield innovative next-generation products."

Read about more about http://www.rxfiber.com/fibers/rxfibron-ht©;.aspx [RxFibron HT __title__ RxFibers RxFibron HT award winning fiber for implantable medical devices] and more about the Golden Mousetrap Award Finalists and Winners on designnews.com. Images from the ceremony will be posted to the Design News Facebook page.

About RxFiber

RxFiber manufactures a wide variety of next-generation, high quality, innovative and custom-designed medical-grade yarn and fiber solutions. As the leading expert in producing multifilament fine denier, high-tenacity fibers with both absorbable and non-absorbable qualities, RxFiber works with customers' medical device needs to provide textile solutions that best match the specifications required to produce reliable and verifiable products. The company develops custom yarns and can replace aging yarn inventory with quality yarn in smaller quantities that meet production specifications. RxFiber also provides small custom fiber runs that can be fully integrated with product specifications and can coordinate and consult on the testing and conversion process. RxFiber's technical experts can also consult on weaving, knitting and braiding solutions that are best aligned with the device specifications.

Brenda Gilchrist, RXFIBER, LLC, http://WWW.RXFIBER.COM, +1 866-308-6025 Ext: 11, [email protected]

Modal title

View PDF
High Tenacity Lower Profile Biomaterial Fiber Wins Golden Mousetrap award
View PDF
High Tenacity Lower Profile Biomaterial Fiber Wins Golden Mousetrap award
View PDF
High Tenacity Lower Profile Biomaterial Fiber Wins Golden Mousetrap award

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.